Three Pharmaceutical Manufacturing Change Agents Profiled in C&EN

“PharmaManufacturing TV” Resumes: Interviews with Puerto Rico’s Governor, Zymogenics’ CEO; Reports on Amgen, Gilead and Weight-L

Dr. Daniel Carlat Starts Up a Continuing Medical Education Blog

Will Acomplia Rejection Mean Trouble for Pfizer and Merck? Rumors of Sanofi-BMS Merger Resurface

Followon Biologics: Paving the Way and Making a Case - FDA’s Draft Guidance and an Update from CEI

Pharma, QbD and Bikash Chatterjee’s “Argument for Change” in FDA and Industry

Big Pharma and Lessons From Detroit’s Big Three: Focus on API Manufacturing, Or Lose Your Edge to Offshore Generics